Nj. Reynolds et al., RETINOIC ACID METABOLITES EXHIBIT BIOLOGICAL-ACTIVITY IN HUMAN KERATINOCYTES, MOUSE MELANOMA-CELLS AND HAIRLESS MOUSE SKIN IN-VIVO, The Journal of pharmacology and experimental therapeutics, 266(3), 1993, pp. 1636-1642
Topical all-trans retinoic acid (RA) modulates growth and differentiat
ion of skin and is used in the treatment of various dermatological dis
orders. RA is metabolized to 4-hydroxy RA, 4-oxo RA and 5,6-epoxy RA,
which are believed to be markedly less active than RA. 3,4-didehydrore
tinoic acid (ddRA) is a metabolite of 3,4-didehydroretinol which is pr
esent in skin. ddRA is biologically active and acts as a morphogen. We
have determined the relative biological activity of ddRA, 4-hydroxy R
A, 4-oxo RA and 5,6-epoxy RA as assessed by three retinoid responsive
systems relevant to skin. RA, ddRA, 4-hydroxy RA, 4-oxo RA and 5,6-epo
xy RA (10-100 nM) reduced epidermal transglutaminase activity in human
keratinocytes to similar extents, and inhibited alpha-melanocyte-stim
ulating hormone-isobutylmethylxanthine-inducible tyrosinase activity i
n Cloudman S-91 mouse melanoma cells by 67, 39, 48, 51 and 19%, respec
tively, at 100 nM. Daily topical application of the retinoids to hairl
ess mouse skin for 4 days resulted in dose-dependent changes in epider
mal thickness and global histological score. The relative potencies of
RA, ddRA, 4-hydroxy RA, 4-oxo RA and 5,6-epoxy RA, as calculated by p
arallel line assay, were 1.0, 0.60, 0.34, 0.29 and 0.18, respectively,
for epidermal hyperplasia and 1.0, 0.78, 0.23, 0.14 and 0.08, respect
ively, for global histological score. Interestingly, the compounds exh
ibited a similar rank order of potency with respect to induction of ce
llular retinoic acid binding protein-II mRNA. These data indicate that
ddRA, 4-hydroxy RA, 4-oxo RA and 5,6-epoxy RA exhibit significant bio
logical activity in human keratinocytes, mouse melanoma cells and mous
e skin, but are in general less potent than RA. Therefore, the RA meta
bolites have the potential to contribute, in part, to the observed cut
aneous biologic effects of RA. Furthermore, ddRA and RA metabolites ma
y play a role in the control of skin growth and differentiation.